Health & Medicine
-
How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients
The FDA has approved VOCERYQ, a novel DNA-based immunotherapy designed to reduce the need for repeated surgical interventions in adults with RRP.
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
UK Trial Aims to Cut Breast Cancer Radiotherapy from Three Weeks to Five Days
Government-funded FAST-Forward Boost trial recruits 1,000 patients across 39 hospitals to test shorter treatment with targeted boost dose.
Personal Finance
-
Why Personal Bankruptcies Jumped 11% Despite Economic Growth
Rising credit costs and eroded savings are driving more Americans to bankruptcy even as GDP expands and unemployment remains low.
-
How Lendmark Financial Services Is Expanding Access to Credit in Local Markets
As Lendmark Financial Services grows its branch network across the Southeast, here is how the lender is shaping personal finance options for…
-
Four in 10 US Adults Carry Health Care Debt as Michigan Wipes Another $21 Million
Learn how insured patients can navigate hospital billing departments, leverage legal protections, and manage unexpected medical debt.
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
Examining how institutional credit partnerships like Viola Credit’s latest deal influence the personal finance landscape and fair lending availability.
Cancer News
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
The numbers first: 1,137 patients, split two to one, all with melanoma that surgeons had already removed. On Wednesday, 19 August 2026,…
Health News
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
-
Nir Barzilai Leads TAME Trial to Test Metformin for Aging
NEW YORK, July 8 — The biology of extreme old age has a meticulous chronicler in Nir Barzilai, the Israeli-American geneticist who…
-
Alois Alzheimer Identified Disease But Colleague Named It
BERLIN, July 8 — On the surface, the story of Alois Alzheimer is a straightforward tale of medical discovery. A German psychiatrist…
World News
-
Too little too late, say parents of youth killed in 2024 protests
Nairobi, June 25 — As Kenya approaches the anniversary of the June 2024 protests, families of the victims are speaking out about…
-
Delhi Palam Blaze Kills Nine Near Magenta Line Station
The fire that tore through a building near Delhi’s Palam metro station on March 18, 2026, killing nine people, has not yet…
-
Saint Petersburg Market Fire Kills 1, Injures 2
A devastating fire swept through a large market in Saint Petersburg, Russia, on December 10, 2025, leaving at least one person dead…
-
Faisalabad Factory Blast Kills 18 Amid Infrastructure Strain
In Faisalabad, the industrial heart of Punjab, the glue factory explosion that killed 18 people and wounded 21 others on November 21,…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Selangor International Care Expo 2026 Targets the Growing Care Economy
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
Waters and Labcorp partner to expand FDA-approved HPV testing options by late 2026
-
Hospital Beds for Critically Ill Kids Vanish as Costs Rise
-
RFK Jr. Orders FDA to Allow Unapproved Peptide Injections
-
New Study Shows Tucatinib Delays Progression in Breast Cancer Spread to Brain
-
FDA Draft Guidance Would Let Individualized Gene Editing Variants Share One License Application
-
Nationwide Lifts Fixed Rate Cash ISAs to 5.00% AER, but Better Rates Exist
-
A $30 Estate-Sale Painting Fetched $1.35 Million: The Tax Hits a Retiree Could Face
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman Says Parents Should Not Fund Trump Accounts Until Their Own Finances Are Solid